Hillary Campbell and Whitt Steineker, Bradley Arant Boult Cummings
The Great Divide: The Feds’ Differing Approach to Psychedelics and Cannabis
Just as we did, the Food and Drug Administration has recognized the growing enthusiasm for exploring opportunities to use psychedelic medications to treat mental health disorders.